Aqdot Revenue and Competitors

Cambridge,

Location

N/A

Total Funding

Estimated Revenue & Valuation

  • Aqdot's estimated annual revenue is currently $3.8M per year.(i)
  • Aqdot's estimated revenue per employee is $122,839

Employee Data

  • Aqdot has 31 Employees.(i)
  • Aqdot grew their employee count by 0% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$13.4M926%N/AN/A
#2
$8.3M17-72%N/AN/A
#3
$6.6M5218%N/AN/A
#4
$203M10125%$65MN/A
#5
$5.6M499%N/AN/A
#6
$12.9M922%$23.1MN/A
#7
$1M12N/AN/AN/A
#8
$106.5M599-17%$2.3MN/A
#9
$33.4M2107%N/AN/A
#10
$36.5M2265%N/AN/A
Add Company

Aqdot is a Cambridge (UK)-based supramolecular chemistry company with a focus and expertise in developing, licensing and selling novel proprietary products. The Aqdot Solutions part of the business works in partnership with customers to understand their challenges and develop solutions utilising the unique AqBit technology. This has the team working in areas from air filtering in transportation to delivery of therapeutics for cancer. In parallel the Aqdot Products part of the company has recently launched its own brands AqStar™ M1 and Oderase to date. Again, working with partners either on a distribution basis, or offering the opportunity to “white label” or develop a market specific formulation.

keywords:N/A

N/A

Total Funding

31

Number of Employees

$3.8M

Revenue (est)

0%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Aqdot's People

NameTitleEmail/Phone
1
Cofounder and Strategy DirectorReveal Email/Phone
2
Project LeaderReveal Email/Phone
3
Dr. Senior technologistReveal Email/Phone
4
Marketing LeaderReveal Email/Phone
5
CEOReveal Email/Phone
6
Business Development ExecutiveReveal Email/Phone
7
Head People and FacilitiesReveal Email/Phone
8
Chief Commercial Officer (CCO)Reveal Email/Phone
9
Senior TechnologistReveal Email/Phone
10
Junior TechnologistReveal Email/Phone
Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$3.6M31-18%N/A
#2
$5.9M31-9%N/A
#3
$3.6M31N/AN/A
#4
$3.6M31N/AN/A
#5
$3.7M317%N/A